← Back to Search

Essential Oils for Intrauterine Device Insertion and Muscle Pain

N/A
Waitlist Available
Led By Vicki F Fresen, RNC, MSN, APNP
Research Sponsored by Aurora Health Care
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older at time of IUD insertion
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15 minutes post oil application/massage
Awards & highlights

Study Summary

This trial will measure the effects of sweet marjoram essential oil + grapeseed oil with massage on uterine cramping/pain post-IUD insertion/placement.

Who is the study for?
This trial is for adults over 18 who speak English and have recently had an IUD inserted. They must have taken NSAIDs before the insertion, signed a consent form, and not be post-partum or allergic to the oils used in the study.Check my eligibility
What is being tested?
The study tests if massaging with sweet marjoram essential oil mixed with grapeseed oil can reduce uterine cramping/pain after getting an IUD. It's a pilot study to see if further research should be done.See study design
What are the potential side effects?
Potential side effects may include skin irritation at the application site or allergic reactions for those sensitive to sweet marjoram essential oil or grapeseed oil.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15 minutes post oil application/massage
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 minutes post oil application/massage for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Pain/Discomfort as Assessed by NRS
Secondary outcome measures
NRS Patient Pain Rating

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Method 1: Sweet Marjoram Essential Oil + Grapeseed Oil with MassageExperimental Treatment1 Intervention
Subjects randomized will receive dilution of sweet marjoram essential oil (mixed with grapeseed oil), which will be applied topically with massage after IUD insertion.
Group II: Method 2: Grapeseed Oil with MassageActive Control1 Intervention
Subjects randomized will grapeseed oil applied topically with massage after IUD insertion.
Group III: Method 3: Control Group (no oil or massage)Active Control1 Intervention
Subjects will serve as control and no essential oils or massage will be applied.

Find a Location

Who is running the clinical trial?

Aurora Health CareLead Sponsor
42 Previous Clinical Trials
15,972 Total Patients Enrolled
Vicki F Fresen, RNC, MSN, APNPPrincipal InvestigatorAurora BayCare Medical Center
Vicki F Fresen, MNS, APNPPrincipal InvestigatorAurora BayCare Medical Center

Media Library

Sweet Marjoram Essential Oil + Grapeseed Oil with Massage Clinical Trial Eligibility Overview. Trial Name: NCT04927741 — N/A
Muscle Pain Research Study Groups: Method 2: Grapeseed Oil with Massage, Method 3: Control Group (no oil or massage), Method 1: Sweet Marjoram Essential Oil + Grapeseed Oil with Massage
Muscle Pain Clinical Trial 2023: Sweet Marjoram Essential Oil + Grapeseed Oil with Massage Highlights & Side Effects. Trial Name: NCT04927741 — N/A
Sweet Marjoram Essential Oil + Grapeseed Oil with Massage 2023 Treatment Timeline for Medical Study. Trial Name: NCT04927741 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has enrollment into this trial been opened?

"Per clinicaltrials.gov, this medical trial is not presently recruiting patients. The study was initially posted on May 27th 2021 and the last update occurred on July 18 2022. Although no longer seeking participants, there are 29 other trials actively enrolling volunteers at this time."

Answered by AI
~16 spots leftby Apr 2025